This inventor holds 5 USPTO granted patents and 2 published patent applications and 3 EPO patents. Top assignees: Accro Bioscience (Hk) Limited, Accro Bioscience Inc., Cgenetech (Suzhou, China) Co., Ltd.. Active years: 2020-2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
3 out of 4 
1 out of 1 
1 out of 5 Years Active: 2020-2026
Title: **Haikuo Ma: Innovator in CXCR4 Pathway Therapeutics**
Introduction
Haikuo Ma is a prominent inventor based in Suzhou, China, known for his contributions to pharmaceutical innovations. With an impressive portfolio of three patents, he focuses on the development of heteroaryl compounds that target critical biological pathways, specifically concerning diseases linked to the CXCR4 pathway and necrosis.
Latest Patents
Haikuo Ma's latest inventions highlight his expertise in medicinal chemistry. One of his notable patents, titled “Heteroaryl Compounds as CXCR4 Inhibitors, Composition and Method Using the Same,” presents a novel class of heteroaryl compounds designed to inhibit the CXCR4 pathway. This patent discusses the synthesis of these compounds, pharmaceutical formulations, and their potential application in treating various diseases and disorders.
Another significant patent is “Heteroaryl Compounds as Inhibitors of Necrosis, Composition and Method Using the Same.” This invention shares a similar framework, detailing heteroaryl compounds aimed at treating conditions related to necrosis. The disclosures in both patents include detailed methodologies for the compounds’ preparation and their therapeutic applications.
Career Highlights
Haikuo Ma has collaborated with notable companies such as Cgenetech (Suzhou, China) Co., Ltd. and Accro Bioscience (HK) Limited. His work in these organizations has facilitated significant advancements in pharmaceutical research and development, particularly in creating innovative therapeutic agents that address unmet medical needs.
Collaborations
Throughout his career, Haikuo Ma has worked alongside talented professionals, including Xiaohu Zhang and Jiyue Zheng. These collaborations have fostered a dynamic research environment, enhancing the development of cutting-edge innovations in the field of drug discovery.
Conclusion
In conclusion, Haikuo Ma's contributions to the field of pharmaceutical sciences exemplify the impact of innovation in healthcare. His patents embody his commitment to developing advanced therapeutic solutions for complex medical challenges. As he continues his work, Haikuo Ma remains a key figure in the quest for effective treatments targeting the CXCR4 pathway and necrosis.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile